Patricia Eckert - 26 May 2023 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)

Role: Interim CFO
Signature: /s/ Patricia Eckert
Issuer symbol: ENZB
Transactions as of: 26 May 2023
Net transactions value: $0
Form type: 4
Filing time: 31 May 2023, 16:18:29 UTC
Previous filing: 15 Nov 2022
Next filing: 27 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ENZ	Common Stock, $0.01 Par Value						19,400	26 May 2023	401k

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENZ	Stock Option (to acquire Common Stock)	Award	$0	+25,000		$0.000000	25,000	26 May 2023	Common Stock	25,000	$2.29	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted 25,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on May 26, 2024.